TCL Archive Undeterred By Randomized Trial Results, AUA Calls For Baseline PSA At Age 40. May 1, 2009
TCL Archive Von Eschenbach takes leave of absence from NCI, resigns from C-Change board. Acting FDA commissioner’s drug approval strategy rooted in unproven science. Von Eschenbach told NCI deputies he might drop in on meetings. Who’s really in charge? October 7, 2005
TCL Archive Continuing Progress Reported On Breast Cancer Treatment; Mammography Controversy Cooled November 26, 1976
TCL Archive In Brief: Boson Hotel Offers Free Rooms to Cancer Patients; Smoking Program Report Available February 1, 1985
